Literature DB >> 229160

Comparison of immunofluorescence and radioimmunoassay for detecting IgM antibody in infants with the congenital rubella syndrome.

J E Cradock-Watson, M K Ridehalgh, J R Pattison, M J Anderson, H O Kangro.   

Abstract

Immunofluorescence (IF) and radioimmunoassay (RIA) have been compared as methods for detecting IgM antibody in 124 infants with confirmed or suspected congenital rubella. IF was used to test sucrose density gradient fractions and RIA to test fractions and whole serum. When fractions were tested IF and RIA were equally specific and distinguished clearly between IgM and IgG, but RIA was the more sensitive method. The RIA titre in whole serum was always greater than in the peak IgM fraction and there was no evidence that testing the serum, rather than the fraction, could result in failure to detect IgM. With some sera RIA gave low titres which became negative after absorption with IgG-coated latex beads. The mechanism of this 'false positive' effect, which may have been due to IgM with anti-IgG activity, was not investigated, but if it can be removed by absorption it need not reduce the specificity of the test. During the first 6 months of life IgM antibody was detected by RIA in 30 out of 32 unfractionated sera and by IF in fractions from 28 of these. After the age of 6 months IgM was found progressively less frequently and the greater sensitivity of RIA became a more obvious advantage: 17 out of 60 specimens were positive by RIA and 11 of these were negative by IF. RIA testing of whole serum appears to be an economical, specific and sensitive method for detecting IgM antibody in congenital rubella, of particular value when the titre of antibody is low.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 229160      PMCID: PMC2130151          DOI: 10.1017/s0022172400026243

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  12 in total

1.  The relationship and significance of antibody titres as determined by various serological methods in glandular and ocular toxoplasmosis.

Authors:  K A Karim; G B Ludlam
Journal:  J Clin Pathol       Date:  1975-01       Impact factor: 3.411

2.  Identification of pregnancies at risk from cytomegalovirus infection.

Authors:  L M de Silva; G L Kampfner; C M Lister; J O Tobin
Journal:  J Hyg (Lond)       Date:  1977-12

3.  Solid-phase radioimmunoassay of rubella virus immunoglobulin G and immunoglobulin M antibodies.

Authors:  K O Kalimo; O H Meurman; P E Halonen; B R Ziola; M K Viljanen; K Granfors; P Toivanen
Journal:  J Clin Microbiol       Date:  1976-08       Impact factor: 5.948

4.  Comparison of methods for detecting specific IgM antibody in infants with congenital rubella.

Authors:  J R Pattison; C M Jackson; J A Hiscock; J E Cradock-Watson; M K Ridehalgh
Journal:  J Med Microbiol       Date:  1978-11       Impact factor: 2.472

5.  Fluorescent staining and human IgM.

Authors:  K B Fraser; P V Shirodaria; C F Stanford
Journal:  Br Med J       Date:  1971-09-18

6.  Specific immunoglobulins in infants with the congenital rubella syndrome.

Authors:  J E Cradock-Watson; M K Ridehalgh
Journal:  J Hyg (Lond)       Date:  1976-02

7.  A rapid immunofluorescent procedure for the detection of specific IgG and IgM antibody in sera using Staphylococcus aureus and latex-IgG as absorbents.

Authors:  S Chantler; E Devries; P R Allen; B A Hurn
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

8.  The detection of rubella-specific IgM antibodies by radioimmunoassay.

Authors:  H O Kangro; J R Pattison; R B Heath
Journal:  Br J Exp Pathol       Date:  1978-12

9.  IgG, IgA and IgM responses in acute rubella determined by the immunofluorescent technique.

Authors:  J E Cradock-Watson; M S Bourne; E M Vandervelde
Journal:  J Hyg (Lond)       Date:  1972-09

10.  Solid-phase radioimmunoassay of rubella virus immunoglobulin M antibodies: comparison with sucrose density gradient centrifugation test.

Authors:  O H Meurman; M K Viljanen; K Granfors
Journal:  J Clin Microbiol       Date:  1977-03       Impact factor: 5.948

View more
  10 in total

1.  Comparison of five different methods of rubella IgM antibody testing.

Authors:  H Cubie; E Edmond
Journal:  J Clin Pathol       Date:  1985-02       Impact factor: 3.411

2.  Evaluation of a radioimmunoassay for IgM-class antibodies against cytomegalovirus.

Authors:  H O Kangro
Journal:  Br J Exp Pathol       Date:  1980-10

3.  Evaluation of a commercial antibody capture enzyme immunoassay for the detection of rubella specific IgM.

Authors:  J Hodgson; P Morgan-Capner
Journal:  J Clin Pathol       Date:  1984-05       Impact factor: 3.411

4.  Comparison of radioimmunoassay and the gel filtration technique for routine diagnosis of rubella during pregnancy.

Authors:  H O Kangro; C Jackson; R B Heath
Journal:  J Hyg (Lond)       Date:  1981-10

5.  Outcome of asymptomatic infection with rubella virus during pregnancy.

Authors:  J E Cradock-Watson; M K Ridehalgh; M J Anderson; J R Pattison
Journal:  J Hyg (Lond)       Date:  1981-10

6.  Hemadsorption immunosorbent technique for determination of rubella immunoglobulin M antibody.

Authors:  J T van der Logt; A M van Loon; J van der Veen
Journal:  J Clin Microbiol       Date:  1981-03       Impact factor: 5.948

7.  Antibody capture radioimmunoassay for anti-rubella IgM.

Authors:  P P Mortimer; R S Tedder; M H Hamblig; M S Shafi; F Burkhardt; U Schilt
Journal:  J Hyg (Lond)       Date:  1981-04

8.  Fetal infection resulting from maternal rubella after the first trimester of pregnancy.

Authors:  J E Cradock-Watson; M K Ridehalgh; M J Anderson; J R Pattison; H O Kangro
Journal:  J Hyg (Lond)       Date:  1980-12

9.  Rubella-specific IgM detected by an antibody capture assay/ELISA technique.

Authors:  J B Kurtz; A Malic
Journal:  J Clin Pathol       Date:  1981-12       Impact factor: 3.411

10.  The WHO programme for prevention and control of viral, chlamydial, and rickettsial diseases. Brief review.

Authors:  F A Assaad; G C Schild
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.